These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12593717)

  • 1. Thyroid-stimulating monoclonal antibodies.
    Sanders J; Jeffreys J; Depraetere H; Richards T; Evans M; Kiddie A; Brereton K; Groenen M; Oda Y; Furmaniak J; Rees Smith B
    Thyroid; 2002 Dec; 12(12):1043-50. PubMed ID: 12593717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function.
    Sanders J; Jeffreys J; Depraetere H; Evans M; Richards T; Kiddie A; Brereton K; Premawardhana LD; Chirgadze DY; Núñez Miguel R; Blundell TL; Furmaniak J; Rees Smith B
    Thyroid; 2004 Aug; 14(8):560-70. PubMed ID: 15320966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
    Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
    Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
    Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
    Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
    Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
    Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor.
    Sanders J; Oda Y; Roberts S; Kiddie A; Richards T; Bolton J; McGrath V; Walters S; Jaskólski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3797-802. PubMed ID: 10523032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
    Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
    Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of serum TSH receptor autoantibody concentration and affinity.
    Nakatake N; Sanders J; Richards T; Burne P; Barrett C; Pra CD; Presotto F; Betterle C; Furmaniak J; Smith BR
    Thyroid; 2006 Nov; 16(11):1077-84. PubMed ID: 17123333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
    Sanders J; Miguel RN; Furmaniak J; Smith BR
    Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding.
    Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R
    Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the thyrotropin binding pocket.
    Jeffreys J; Depraetere H; Sanders J; Oda Y; Evans M; Kiddie A; Richards T; Furmaniak J; Rees Smith B
    Thyroid; 2002 Dec; 12(12):1051-61. PubMed ID: 12593718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
    Hill BL; Erlanger BF
    Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
    Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
    Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of thyroid-stimulating blocking antibodies that appeared during transient hypothyroidism after radioactive iodine therapy.
    Kung AW; Lau KS; Kohn LD
    Thyroid; 2000 Oct; 10(10):909-17. PubMed ID: 11081257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human thyrotropin (TSH) receptor in a TSH binding inhibition assay for TSH receptor autoantibodies.
    Kakinuma A; Chazenbalk GD; Jaume JC; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2129-34. PubMed ID: 9215283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a thyroid-stimulating human monoclonal autoantibody (M22) on functional activity of LH and FSH receptors.
    Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Pinchera A; Sanders J; Evans M; Richards T; Furmaniak J; Smith BR
    Thyroid; 2006 Nov; 16(11):1085-9. PubMed ID: 17123334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample.
    Evans M; Sanders J; Tagami T; Sanders P; Young S; Roberts E; Wilmot J; Hu X; Kabelis K; Clark J; Holl S; Richards T; Collyer A; Furmaniak J; Smith BR
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):404-12. PubMed ID: 20550534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin (TSH) receptor autoantibodies do not appear to bind to the TSH receptor produced in an in vitro transcription/translation system.
    Prentice L; Sanders JF; Perez M; Kato R; Sawicka J; Oda Y; Jaskolski D; Furmaniak J; Smith BR
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1288-92. PubMed ID: 9100609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.